Overview
- On X, Donald Trump Jr. endorsed Mark Cuban’s assertion that pharmacy benefit managers corrupt healthcare and drive up drug costs.
- Cuban noted that three major PBMs negotiate over 90% of commercial plan rebates and manipulate formularies to boost their revenue.
- He called for separating formulary control from PBMs and forcing Medicare Advantage and Part D plans to buy lower-priced drugs from any provider.
- Arkansas enacted a law barring PBMs from owning or controlling pharmacies after an FTC report criticized their unfair terms imposed on independent pharmacies.
- Federal lawmakers are drafting budget reconciliation provisions to regulate spread pricing and increase transparency in PBM operations.